Disc Medicine (IRON) Short term Debt (2020 - 2022)

Disc Medicine (IRON) has 3 years of Short term Debt data on file, last reported at $2.9 million in Q2 2022.

• Short term Debt for Q2 2022 came in at $2.9 million, down 41.74% year-over-year; the trailing twelve-month figure through Jun 2022 was $2.9 million (down 41.74% YoY), and the FY2021 annual result was $6.4 million, up 29.0% from the prior year.
• Short term Debt retreated to $2.9 million in Q2 2022 per IRON's latest filing, from $4.2 million in the prior quarter.
• Over five years, Short term Debt peaked at $6.4 million in Q4 2021 and troughed at $2.9 million in Q2 2022.
• A 3-year average of $4.8 million and a median of $5.0 million in 2020 frame the typical range for Short term Debt.
• The sharpest annual moves came in 2021 and 2022: Short term Debt grew 29.0% in 2021, then slumped 41.74% in 2022.
• A 3-year view of Short term Debt shows it stood at $5.0 million in 2020, then climbed by 29.0% to $6.4 million in 2021, then sank by 54.84% to $2.9 million in 2022.
• Business Quant data shows IRON's Short term Debt at $2.9 million in Q2 2022, $4.2 million in Q1 2022, and $6.4 million in Q4 2021.